These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 33739190)

  • 21. The clinical utility of professional continuous glucose monitoring by pharmacists for patients with type 2 diabetes.
    Ulrich H; Bowen M
    J Am Pharm Assoc (2003); 2021; 61(6):e76-e82. PubMed ID: 34154906
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of Clinical Pharmacist Intervention on Hemoglobin A1C Reduction in Veteran Patients With Type 2 Diabetes in a Rural Setting.
    Sullivan J; Jett BP; Cradick M; Zuber J
    Ann Pharmacother; 2016 Dec; 50(12):1023-1027. PubMed ID: 27497068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of Visit Frequency of Pharmacist-Led Diabetes Medication Management Program.
    Frederick A; Juan J; Ivy D; Maldonado YM
    J Pharm Pract; 2022 Feb; 35(1):70-74. PubMed ID: 32830604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improving Chronic Disease Outcomes Through Medication Therapy Management in Federally Qualified Health Centers.
    Rodis JL; Sevin A; Awad MH; Porter B; Glasgow K; Hornbeck Fox C; Pryor B
    J Prim Care Community Health; 2017 Oct; 8(4):324-331. PubMed ID: 28381095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacist-physician collaborative care model for patients with uncontrolled type 2 diabetes in Brazil: results from a randomized controlled trial.
    Aguiar PM; da Silva CHP; Chiann C; Dórea EL; Lyra DP; Storpirtis S
    J Eval Clin Pract; 2018 Feb; 24(1):22-30. PubMed ID: 27452158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessing the effectiveness of pharmacist-directed medication therapy management in improving diabetes outcomes in patients with poorly controlled diabetes.
    Skinner JS; Poe B; Hopper R; Boyer A; Wilkins CH
    Diabetes Educ; 2015 Aug; 41(4):459-65. PubMed ID: 26009557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of Pharmacists' Work in a Physician-Pharmacist Collaborative Model for the Management of Hypertension.
    Isetts BJ; Buffington DE; Carter BL; Smith M; Polgreen LA; James PA
    Pharmacotherapy; 2016 Apr; 36(4):374-84. PubMed ID: 26893135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacist-led group medical appointment model in type 2 diabetes.
    Taveira TH; Friedmann PD; Cohen LB; Dooley AG; Khatana SA; Pirraglia PA; Wu WC
    Diabetes Educ; 2010; 36(1):109-17. PubMed ID: 19966072
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improved Glycemic Control Outcomes Regardless of Mental Health Disorders in a Pharmacist-Endocrinologist Diabetes Intense Medical Management (DIMM) "Tune Up" Clinic.
    Morello CM; Nguyen T; Tao L; Hirsch JD
    Ann Pharmacother; 2020 Sep; 54(9):858-865. PubMed ID: 32100551
    [No Abstract]   [Full Text] [Related]  

  • 30. Pharmacist impact on health outcomes in a homeless population.
    Bahrami S; Chang C; Alvarez KS; Lutek K; Nguyen S; Hegde A
    J Am Pharm Assoc (2003); 2020; 60(3):485-490. PubMed ID: 31901441
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of pharmacist-administered diabetes mellitus education and management services.
    Ragucci KR; Fermo JD; Wessell AM; Chumney EC
    Pharmacotherapy; 2005 Dec; 25(12):1809-16. PubMed ID: 16305300
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacist collaborative management of poorly controlled diabetes mellitus: a randomized controlled trial.
    Jameson JP; Baty PJ
    Am J Manag Care; 2010 Apr; 16(4):250-5. PubMed ID: 20394460
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacist-led telehealth disease management program for patients with diabetes and depression.
    Cohen LB; Taveira TH; Wu WC; Pirraglia PA
    J Telemed Telecare; 2020 Jun; 26(5):294-302. PubMed ID: 30691328
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systematic Review and Meta-Analysis of Medication Reviews Conducted by Pharmacists on Cardiovascular Diseases Risk Factors in Ambulatory Care.
    Martínez-Mardones F; Fernandez-Llimos F; Benrimoj SI; Ahumada-Canale A; Plaza-Plaza JC; S Tonin F; Garcia-Cardenas V
    J Am Heart Assoc; 2019 Nov; 8(22):e013627. PubMed ID: 31711390
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of pharmacist care for hypertension in the Veterans Affairs patient-centered medical home: a retrospective case-control study.
    Zillich AJ; Jaynes HA; Bex SD; Boldt AS; Walston CM; Ramsey DC; Sutherland JM; Bravata DM
    Am J Med; 2015 May; 128(5):539.e1-6. PubMed ID: 25534422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of a community pharmacist-delivered diabetes support program for patients receiving specialty medical care: a randomized controlled trial.
    Jahangard-Rafsanjani Z; Sarayani A; Nosrati M; Saadat N; Rashidian A; Hadjibabaie M; Ashouri A; Radfar M; Javadi M; Gholami K
    Diabetes Educ; 2015 Feb; 41(1):127-35. PubMed ID: 25420946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of a pharmacist-driven, collaborative practice on diabetes management in an Urban underserved population: a mixed method assessment.
    Ray S; Lokken J; Whyte C; Baumann A; Oldani M
    J Interprof Care; 2020; 34(1):27-35. PubMed ID: 31381470
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of a pharmacist-managed hypertension program on health system costs: an evaluation of the Study of Cardiovascular Risk Intervention by Pharmacists-Hypertension (SCRIP-HTN).
    Houle SK; Chuck AW; McAlister FA; Tsuyuki RT
    Pharmacotherapy; 2012 Jun; 32(6):527-37. PubMed ID: 22552863
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improved Glycemic Control With Minimal Change in Medication Regimen Complexity in a Pharmacist-Endocrinologist Diabetes Intense Medical Management (DIMM) "Tune Up" Clinic.
    Morello CM; Rotunno T; Khoan J; Hirsch JD
    Ann Pharmacother; 2018 Nov; 52(11):1091-1097. PubMed ID: 29775079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Federal Bureau of Prisons clinical pharmacy program improves patient A1C.
    Bingham JT; Mallette JJ
    J Am Pharm Assoc (2003); 2016; 56(2):173-7. PubMed ID: 27000168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.